Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsDrreddyslaboratories

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Sell Dr Reddy's Laboratories on bounce: Sandeep Wagle

      According to Sandeep Wagle of powermywealth.com, one may sell Dr Reddy's Laboratories on bounce back towards Rs 2,700-2,750.

    • Exit Dr Reddy's Laboratories: Shahina Mukadam

      Shahina Mukadam, Independent Market Expert advises exiting Dr Reddy's Laboratories.

    • Buy Dewan Housing Finance Corporation, Amara Raja Batteries, Bharat Petroleum Corporation: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Dewan Housing Finance Corporation, Amara Raja Batteries and Bharat Petroleum Corporation.

    • Buy J Kumar Infraprojects, Titan Company, Dr Reddy's Labs: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying J Kumar Infraprojects, Titan Company and Dr Reddy's Labs.

    • Here are a few investment ideas by SP Tulsian

      In an interview to CNBC-TV18's Latha Venkatesh, Sonia Shenoy and Anuj Singhal, SP Tulsian of sptulsian.com shared his reading and outlook on the market and also gave recommendations on various stocks.

    • Buy, Sell, Hold: Are these stocks present in your portfolio?

      Motilal Oswal has initiated coverage with a buy rating and has set a target price at Rs 229.

    • Expect 15-20% cut in Divis Labs' FY18-FY19 EPS estimates: HDFC Sec

      In an interview to CNBC-TV18, Amey Chalke, Pharma Analyst at HDFC Securities shared his readings and outlook on Divis Laboratories and Dr Reddys Laboratories.

    • Buy L&T, HUL; sell Apollo Hospitals, Idea Cellular; avoid Dr Reddy's Labs: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy L&T and HUL and sell Apollo Hospitals and Idea Cellular while one can avoid Dr Reddy's Labs.

    • Buy, sell, hold: Analysts have these 8 stocks on their radar today

      Bank of America Merrill Lynch has reiterated a buy call on HCL Technologies with an upward revision in target price to Rs 990 from Rs 935 a share.

    • Buy, sell, hold: Analysts have these 8 stocks on their radar today

      Bank of America Merrill Lynch has reiterated a buy call on HCL Technologies with an upward revision in target price to Rs 990 from Rs 935 a share.

    • Buy Dewan Housing Finance, Ceat, Dr Reddy's Labs: Yogesh Mehta

      Yogesh Mehta of Motilal Oswal suggests buying Dewan Housing Finance, Ceat and Dr Reddy's Labs.

    • Buy Colgate Palmolive, sell Dr Reddy's Labs: Mitessh Thakkar

      According to Mitessh Thakkar of miteshthacker.com, one can buy Colgate Palmolive and sell Dr Reddy's Labs.

    • Despite USFDA woes, Nirmal Bang has hold rating on Dr Reddy's

      Vishal Manchanda, pharma analyst at Nirmal Bang said that Dr Reddy‘s Laboratories revenue won‘t be impacted by the observation received at the Duvvada plant and has a hold rating on the stock. He said one has to wait for further clarity about the nature of observations.

    • Buy YES Bank, Dr Reddy's Labs may head lower: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com suggests buying YES Bank while he feels that shorts are opening up in Dr Reddy's Laboratories.

    • Here are top trading ideas from Rahul Arora

      In an interview to CNBC-TV18's Prashant Nair and Sumaira Abidi, Rahul Arora, CEO at Nirmal Bang Institutional Equities shared his readings and outlook on market and specific stocks.

    • Buy, sell, hold: 8 stocks that you can focus today

      JPMorgan has overweight rating on L&T, with a target price at Rs 1,670 as the brokerage house is optimistic about a pick-up in execution in the near-term.

    • Here‘s why Credit Suisse has ‘underperform‘ rating on Dr Reddy‘s

      Brokerage house cites high product concentration playing out now with other firms getting approvals for products having high market share for the pharma major.

    • Buy, sell, hold: 5 stocks that you can focus today

      Morgan Stanley sees limited impact on HPCL/BPCL if government transfers ownership to ONGC. ONGC's leverage could rise in the near-term and HPCL/BPCL could lower ONGC's leverage only by FY20-21, it feels.

    • Sell SBI, Pidilite, Dr Reddy's; buy TCS, Divis Labs: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can sell State Bank of India, Pidilite Industries and Dr Reddy's Laboratories and buy Tata Consultancy Services and Divis Laboratories.

    • Here‘s why Deutsche Bank is upbeat on pharmaceutical sector

      Easing regulatory concerns and actions by the US Food and Drug Administration (FDA) will help the sector and improve investor sentiment, Deutsche Bank said in a report.

    • Buy, sell, hold: 8 stocks to watch out for your portfolio

      Morgan Stanley feels any interest in Axis Bank will be based on its retail franchise as it is one of the few banks with a strong retail deposit franchise.

    • Sell Havells, Dr Reddy's; buy Petronet, Siemens: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can sell Havells India and Dr Reddy's Labs and advises buying Petronet LNG and Siemens.

    • Buy, sell, hold: 7 stocks analysts are watching out

      Goldman Sachs says Kotak Mahindra Bank may outperform on improving growth prospects & top quartile EPS growth. Lending book is likely to grow at 25 percent hereon, it feels.

    • Buy Dr Reddy‘s Laboratories 2850 Put: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com is of the view that one can buy Dr Reddy‘s Laboratories 2850 Put while he feels that the trend in Tata Motors DVR is on the downside.

    • Buy, sell, hold: 7 stocks analysts are watching out

      Morgan Stanley also says Jubilant Foodworks' earnings are ahead of estimates and there was impressive cost control. It is best placed to capitalise on urban consumption recovery, it feels. The research firm is overweight on the Stock, with a target price at Rs 1,230.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347